ArticleScientific reports2026
DFT based photophysical assessment of 2-substituted-3-(pyridin-2-yl)-benzo-[d][1,3]-azaphosphole P-oxide for organic optoelectronic applications.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
P-containing heterocycles such as 1,3-benzazaphospholes offer a versatile platform for tunable organic semiconductors. This computational study demonstrates that replacing a terminal phenyl group with a pyridin-2-yl unit in 2-substituted benzo-[d][1,3]- azaphosphole P-oxides reconfigures the intramolecular charge-transfer pathway. Fragment orbital analysis quantifies this inversion: the pyridine (PY) ring contributes 52–75% of HOMO density, establishing it as the electron donor, while the opposing aryl (AR) substituent contributes 33–59% of LUMO density, functioning as the acceptor. This electronic reconfiguration creates a push-pull framework where the AR group dictates optoelectronic properties across three distinct classes. π-extended heteroacene derivatives (6–9) exhibit tunable emission (367–515 nm) with high oscillator strengths, enhanced nonlinear optical response (β up to 2621 a.u.), and favorable hole transport (λh = 0.20–0.28 eV). Thermal stability improves with π-extension (P-C BDE > 78 kcal/mol). Across the series, all properties scale with HOMO-LUMO spatial separation establishing a unified mechanistic framework where greater orbital separation systematically red-shifts emission, lowers reorganization energy, narrows ΔEST, and increases hyperpolarizability. Three compounds emerge with particularly favorable combinations: 6 (cyan emission, λh = 0.22 eV, β = 1871 a.u.), 7 (blue emission, highest f = 0.793, β = 2621 a.u.), and 8 (orange emission, balanced λh/λe, highest BDE = 80.3 kcal/mol). These computational predictions, provide a foundation for rational design of P-based organic semiconductors, with compounds 6–8 prioritized for experimental validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.